Oakland, CA, United States of America

Cary Liberman

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Myolex Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cary Liberman - Innovator in Bioimpedance Measurement

Introduction

Cary Liberman is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of bioimpedance measurement, particularly through his innovative patent. His work focuses on developing portable devices that enhance the measurement of bioimpedance-related properties of tissue.

Latest Patents

Cary Liberman holds a patent for an "Enhanced measurements of bioimpedance." This portable device is designed to measure a bioimpedance-related property of tissue. It features a plurality of electrodes arranged in a specific pattern on a surface, along with associated software. This technology allows for the measurement of bio-impedance related data from localized regions of tissue and calculates health-related parameters based on the measured data. The calculated parameters may represent the muscular health of the localized tissue region. He has 1 patent to his name.

Career Highlights

Cary Liberman is currently associated with Myolex Inc., where he continues to work on advancements in bioimpedance technology. His career reflects a commitment to improving health monitoring through innovative devices.

Collaborations

Cary has collaborated with notable professionals in his field, including Seward B Rutkove and Elmer C Lupton. These collaborations have contributed to the development and refinement of his inventions.

Conclusion

Cary Liberman's work in bioimpedance measurement exemplifies innovation in health technology. His contributions are paving the way for advancements in understanding muscular health through portable measurement devices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…